U.S. Industrial REITs Stock News

NasdaqGS:GILT
NasdaqGS:GILTCommunications

Gilat Satellite Networks (NasdaqGS:GILT) Margin Gains Reinforce Bullish Earnings Narratives In Q1 2026

Gilat Satellite Networks (NasdaqGS:GILT) opened 2026 with Q1 revenue of US$110.5 million and basic EPS of US$0.07. This set the tone for how its growth story is feeding through to the bottom line. The company reported revenue of US$92.0 million and an EPS loss of US$0.11 in Q1 2025, compared to revenue of US$110.5 million and an EPS profit of US$0.07 in Q1 2026. Trailing 12 month EPS is US$0.50 on revenue of US$470.1 million, which points to earnings growth supported by wider net margins. For...
NYSE:AKA
NYSE:AKASpecialty Retail

AKA Brands Holding Q1 Loss Narrows Challenging Bearish Narratives On Persistent Unprofitability

a.k.a. Brands Holding (AKA) has opened 2026 with Q1 revenue of US$132.5 million and a reported loss of US$7.1 million, which translates to basic EPS of US$0.66 in the red. Over the past year, the company has seen trailing twelve month revenue sit at US$604.0 million with a loss of US$30.2 million, or basic EPS of US$2.81 in the red, setting a clear backdrop of continued unprofitability. For investors, the latest quarter keeps the spotlight firmly on margins and on whether the current profile...
NYSE:PSFE
NYSE:PSFEDiversified Financial

Paysafe (PSFE) Q1 Loss Deepens And Tests Bulls On Turnaround Narrative

Paysafe (PSFE) opened 2026 with Q1 revenue of US$442.7 million and a loss of US$36.5 million on a net income basis, which translated to basic EPS of a US$0.71 loss. Over the past five quarters, the company has seen revenue move from US$420.1 million in Q4 2024 to US$401 million in Q1 2025 and then to US$442.7 million in Q1 2026. Over the same period, basic EPS shifted from a profit of US$0.55 in Q4 2024 to losses of US$0.33 in Q1 2025 and US$0.71 in Q1 2026. For investors, the latest report...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

Will Softer Q1 2026 Earnings and EPS Compression Change International General Insurance Holdings' (IGIC) Narrative?

International General Insurance Holdings Ltd. has reported past first-quarter 2026 results, with revenue of US$125.7 million and net income of US$21.7 million, both lower than the same period a year earlier. The drop in diluted earnings per share from continuing operations to US$0.49 from US$0.59 highlights pressure on profitability despite the company’s diversified insurance portfolio. We’ll now examine how this earnings softness, particularly the year-over-year net income decline, may...
NasdaqGS:JACK
NasdaqGS:JACKHospitality

Jack In The Box (JACK) Same Restaurant Sales Decline Challenges Bullish Turnaround Narrative

Jack in the Box (JACK) opened Q2 2026 with total revenue of US$254.3 million and basic EPS of US$0.65, alongside net income excluding extra items of US$12.5 million, setting the tone for how its turnaround story is tracking. The company has seen quarterly revenue move between US$265.7 million and US$371.1 million over the past five reported periods, while basic EPS has ranged from US$0.30 to US$1.63. This gives investors a clear view of how earnings power has shifted through recent quarters...
NasdaqGS:KRNT
NasdaqGS:KRNTMachinery

Kornit Digital (KRNT) Q1 Loss Of US$8.2 Million Challenges Recurring Revenue Stability Narrative

Kornit Digital (NasdaqGS:KRNT) opened Q1 2026 with revenue of US$48.5 million and a basic EPS loss of US$0.19, alongside a quarterly net loss of US$8.2 million, setting a cautious tone for the latest update. Over recent periods the company has seen revenue move from US$60.7 million in Q4 2024 to US$58.9 million in Q4 2025 and then to US$48.5 million in Q1 2026. EPS has swung between a profit of US$0.05 and losses such as US$0.17 and US$0.19, which keeps the spotlight firmly on margin pressure...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Why Vicor (VICR) Is Up 11.2% After AI‑Driven Q1 Beat And Heavy Insider Selling

In early May 2026, Vicor reported strong first-quarter results tied to AI and data‑center power demand, while multiple executives and directors exercised stock options and sold shares, alongside JPMorgan disclosing a 6.2% passive stake. The combination of robust AI‑related momentum and heavy insider selling, with no insider purchases over the past year, is sharpening investor focus on how management views Vicor’s current valuation and risk‑reward balance. Against this backdrop of strong AI...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum Holdings (AMTM) Q2 Margins Near 1% Test Bullish Earnings Rebound Narrative

Amentum Holdings (AMTM) has released its Q2 2026 results with revenue of US$3.5b and net income of US$54m, translating to basic EPS of US$0.22 for the quarter and trailing twelve month EPS of US$0.61. The company has seen quarterly revenue move between US$3.2b and US$3.9b over the past six reported periods, while quarterly basic EPS has ranged from US$0.02 to US$0.22. This sets up a picture of modest top line progress paired with gradually improving earnings power. For investors, the key...
NasdaqGS:ENTA
NasdaqGS:ENTABiotechs

Enanta Pharmaceuticals (ENTA) Q2 Loss Improvement Tests Bearish Profitability Narratives

Enanta Pharmaceuticals (ENTA) has just posted Q2 2026 results with revenue of US$17.2 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$69.2 million and a basic EPS loss of US$2.47. Over recent quarters the company has seen revenue move between US$14.9 million and US$18.6 million, with quarterly basic EPS losses ranging from roughly US$0.41 to US$1.06 and trailing twelve month net losses of US$62.0 million. For investors, the story this quarter is...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

Why COMPASS Pathways (CMPS) Is Up 13.1% After FDA Fast-Track Moves For COMP360 Profit Shift

In the first quarter of 2026, COMPASS Pathways reported net income of US$91.2 million, or US$0.71 per share, and announced U.S. FDA acceptance of a rolling New Drug Application and a National Priority Review Voucher for its COMP360 psilocybin therapy in treatment-resistant depression. This combination of an accounting-driven swing to profitability and accelerated regulatory review for COMP360 marks a key moment for COMPASS Pathways’ shift from pure R&D focus toward potential commercial...
NYSE:IBM
NYSE:IBMIT

A Look At IBM (IBM) Valuation As Shares Decline Despite Strong Multi Year Returns

Stock performance and business profile International Business Machines (IBM) has delivered mixed share performance recently, with the stock up about 91% over the past 3 years but down 25% year to date and 16% over the past year. At a recent close of US$218.37 and a market value of about US$201.7b, IBM sits among the larger US technology and services companies. It combines software, consulting, infrastructure and financing under one umbrella. The company reports annual revenue of US$68.9b and...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON (NasdaqGS:VEON) Q1 EPS Leans On One Off Gain Challenging Earnings Quality Narratives

VEON (NasdaqGS:VEON) has opened 2026 with Q1 numbers that put the focus squarely on earnings quality, reporting US$1.2 billion in revenue and basic EPS of US$1.42, while trailing twelve month EPS sits at US$7.65 on revenue of US$4.6 billion. Over recent quarters the company has seen revenue move from US$998 million in Q4 2024 to US$1.03 billion in Q1 2025, US$1.09 billion in Q2 2025 and US$1.20 billion in Q1 2026, with quarterly EPS ranging from a loss of US$2.00 in Q3 2025 to US$8.50 in Q2...
NYSE:ENS
NYSE:ENSElectrical

Assessing EnerSys (ENS) Valuation After New Focus On Data Centers And Defense Power Systems

Why EnerSys is back in focus after its latest growth update EnerSys (ENS) has drawn fresh attention after outlining plans to expand in data centers and defense, including reallocating manufacturing capacity and steering its Greenville lithium facility toward drones and soldier power systems. See our latest analysis for EnerSys. The recent communications on AI infrastructure and defense electrification sit alongside very strong momentum, with a 30 day share price return of 20.45%, a year to...
NasdaqCM:QUIK
NasdaqCM:QUIKSemiconductor

QuickLogic (QUIK) Q1 Losses Persist Despite Higher Revenue Challenging Bullish Profitability Narratives

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

How Investors May Respond To Perella Weinberg Partners (PWP) Profit Drop, Dividend Hold And Expanded CFO Role

Perella Weinberg Partners recently reported first-quarter 2026 results showing net income of US$1.49 million, down sharply from US$17.34 million a year earlier, while also affirming a quarterly dividend of US$0.07 per Class A share payable in June. Alongside the weaker quarter, the firm expanded Chief Financial Officer Alexandra Gottschalk’s remit to include Chief Operating Officer, highlighting a tighter focus on operational execution as management cited longer timelines to complete complex...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro (HAS) Q1 Profit Challenges Ongoing Trailing Twelve Month Loss Narrative

Hasbro’s Q1 2026 earnings in focus Hasbro (HAS) opened 2026 with Q1 revenue of US$1,000.2 million and basic EPS of US$1.41, setting a clear snapshot of the business against a current share price of US$95.65. Over recent quarters the company has seen revenue move from US$887.1 million in Q1 2025 to US$1,000.2 million in Q1 2026, while basic EPS shifted from US$0.71 to US$1.41 over the same period. This gives investors a clearer look at how the top line and per share earnings are tracking. With...
NYSEAM:LCTX
NYSEAM:LCTXBiotechs

Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives

Lineage Cell Therapeutics (LCTX) opened 2026 with Q1 revenue of US$1.7 million and a basic EPS loss of US$0.02, as net income excluding extraordinary items came in at a loss of US$4.8 million. The company has seen quarterly revenue move between US$1.5 million and US$6.6 million over the past year, while EPS has ranged from a loss of around US$0.13 per share to a small profit of US$0.00 per share, presenting a mixed picture regarding the path toward better margins. For investors, the latest...
NYSEAM:ESP
NYSEAM:ESPElectrical

Espey Mfg. & Electronics (ESP) Non Cash Heavy 25.5% Margin Challenges Bullish Earnings Narratives

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

Assessing GH Research (GHRS) Valuation After New Shelf Registration And Follow On Equity Plan

Capital raising moves put GH Research in focus GH Research (GHRS) has filed a universal shelf registration of up to US$400 million across multiple securities, alongside a US$200 million at-the-market follow-on equity program for its ordinary shares. See our latest analysis for GH Research. The capital raising plans come after a strong run, with the share price at US$21.88 and a 30 day share price return of 33.9%. The 1 year total shareholder return of 119.24% and 3 year total shareholder...
NasdaqGS:MXCT
NasdaqGS:MXCTLife Sciences

MaxCyte (MXCT) EPS Loss Narrows In Q1 2026 Challenging Bearish Profitability Narratives

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...
NYSE:CMDB
NYSE:CMDBShipping

Costamare Bulkers Holdings (CMDB) Q1 Profitability Challenges Longstanding Bearish Earnings Narratives

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Profitable AI Stocks One Debt Free Earner One Quiet Chip Powerhouse

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...
NYSE:CF
NYSE:CFChemicals

Is It Too Late To Reassess CF Industries (CF) After Its Strong 2025 Rally?

If you are wondering whether CF Industries Holdings at US$122.97 is still offering value after its run, the next sections walk through what the current price may be baking in. The stock has returned 3.6% over the last 7 days, 3.4% over the past month, 53.5% year to date and 45.1% over the last year, so recent performance is front of mind for many investors assessing what comes next. Recent news coverage has focused on CF Industries Holdings as a key player in the fertilizers and chemicals...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Assessing CareTrust REIT (CTRE) Valuation After Raised 2026 Guidance And Strong First Quarter Results

CareTrust REIT (CTRE) raised its 2026 earnings guidance and shared first quarter results that showed higher revenue and net income, giving investors fresh data on how the healthcare focused landlord is currently performing. See our latest analysis for CareTrust REIT. The stock has gained 15.48% year to date on a share price basis to $41.93, while the 1 year total shareholder return of 52.47% and 3 year total shareholder return above 7x suggest momentum has been strong over multiple...